They have a credit line, will easily be able to get regular non-convertible financing, and already have reserved shares set aside for production agreements once Fluticare is approved. If approval hits they're in pretty good shape, if it doesn't a reverse split is the least of my worries.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.